183 related articles for article (PubMed ID: 22261944)
1. Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools.
Wright A; Feblowitz J; Phansalkar S; Liu J; Wilcox A; Keohane CA; Seger DL; Bloomrosen M; Kuperman GJ; Bates DW
Am J Health Syst Pharm; 2012 Feb; 69(3):221-7. PubMed ID: 22261944
[TBL] [Abstract][Full Text] [Related]
2. Nature of preventable adverse drug events in hospitals: a literature review.
Kanjanarat P; Winterstein AG; Johns TE; Hatton RC; Gonzalez-Rothi R; Segal R
Am J Health Syst Pharm; 2003 Sep; 60(17):1750-9. PubMed ID: 14503111
[TBL] [Abstract][Full Text] [Related]
3. Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention.
Hug BL; Witkowski DJ; Sox CM; Keohane CA; Seger DL; Yoon C; Matheny ME; Bates DW
J Gen Intern Med; 2010 Jan; 25(1):31-8. PubMed ID: 19894081
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug events in surgical patients: an observational multicentre study.
de Boer M; Boeker EB; Ramrattan MA; Kiewiet JJ; Dijkgraaf MG; Boermeester MA; Lie-A-Huen L
Int J Clin Pharm; 2013 Oct; 35(5):744-52. PubMed ID: 23722455
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care.
Thomsen LA; Winterstein AG; Søndergaard B; Haugbølle LS; Melander A
Ann Pharmacother; 2007 Sep; 41(9):1411-26. PubMed ID: 17666582
[TBL] [Abstract][Full Text] [Related]
6. Ambulatory Computerized Prescribing and Preventable Adverse Drug Events.
Overhage JM; Gandhi TK; Hope C; Seger AC; Murray MD; Orav EJ; Bates DW
J Patient Saf; 2016 Jun; 12(2):69-74. PubMed ID: 26001546
[TBL] [Abstract][Full Text] [Related]
7. Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study.
Aljadhey H; Mahmoud MA; Ahmed Y; Sultana R; Zouein S; Alshanawani S; Mayet A; Alshaikh MK; Kalagi N; Al Tawil E; El Kinge AR; Arwadi A; Alyahya M; Murray MD; Bates D
BMJ Open; 2016 Jul; 6(7):e010831. PubMed ID: 27406640
[TBL] [Abstract][Full Text] [Related]
8. Impact of vendor computerized physician order entry in community hospitals.
Leung AA; Keohane C; Amato M; Simon SR; Coffey M; Kaufman N; Cadet B; Schiff G; Zimlichman E; Seger DL; Yoon C; Song P; Bates DW
J Gen Intern Med; 2012 Jul; 27(7):801-7. PubMed ID: 22271271
[TBL] [Abstract][Full Text] [Related]
9. Impact of vendor computerized physician order entry on patients with renal impairment in community hospitals.
Leung AA; Schiff G; Keohane C; Amato M; Simon SR; Cadet B; Coffey M; Kaufman N; Zimlichman E; Seger DL; Yoon C; Bates DW
J Hosp Med; 2013 Oct; 8(10):545-52. PubMed ID: 24101539
[TBL] [Abstract][Full Text] [Related]
10. Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.
Dequito AB; Mol PG; van Doormaal JE; Zaal RJ; van den Bemt PM; Haaijer-Ruskamp FM; Kosterink JG
Drug Saf; 2011 Nov; 34(11):1089-100. PubMed ID: 21981436
[TBL] [Abstract][Full Text] [Related]
11. Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data.
Kuklik N; Stausberg J; Amiri M; Jöckel KH
BMC Health Serv Res; 2019 Aug; 19(1):555. PubMed ID: 31395053
[TBL] [Abstract][Full Text] [Related]
12. Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy.
Klopotowska JE; Wierenga PC; Stuijt CC; Arisz L; Dijkgraaf MG; Kuks PF; Asscheman H; de Rooij SE; Lie-A-Huen L; Smorenburg SM;
PLoS One; 2013; 8(8):e71045. PubMed ID: 23940688
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of medication-related clinical decision support over-rides in the intensive care unit.
Wong A; Amato MG; Seger DL; Rehr C; Wright A; Slight SP; Beeler PE; Orav EJ; Bates DW
BMJ Qual Saf; 2018 Sep; 27(9):718-724. PubMed ID: 29440481
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for hospital admissions associated with adverse drug events.
Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
[TBL] [Abstract][Full Text] [Related]
15. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports.
Winterstein AG; Hatton RC; Gonzalez-Rothi R; Johns TE; Segal R
Am J Health Syst Pharm; 2002 Sep; 59(18):1742-9. PubMed ID: 12298112
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of preventable adverse drug events: a review of the literature.
von Laue NC; Schwappach DL; Koeck CM
Wien Klin Wochenschr; 2003 Jul; 115(12):407-15. PubMed ID: 12918183
[TBL] [Abstract][Full Text] [Related]
17. The costs of adverse drug events in community hospitals.
Hug BL; Keohane C; Seger DL; Yoon C; Bates DW
Jt Comm J Qual Patient Saf; 2012 Mar; 38(3):120-6. PubMed ID: 22435229
[TBL] [Abstract][Full Text] [Related]
18. High rates of adverse drug events in a highly computerized hospital.
Nebeker JR; Hoffman JM; Weir CR; Bennett CL; Hurdle JF
Arch Intern Med; 2005 May; 165(10):1111-6. PubMed ID: 15911723
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of an electronic medication ordering system (CPOE/CDSS) in hospitalized patients.
Vermeulen KM; van Doormaal JE; Zaal RJ; Mol PG; Lenderink AW; Haaijer-Ruskamp FM; Kosterink JG; van den Bemt PM
Int J Med Inform; 2014 Aug; 83(8):572-80. PubMed ID: 24929633
[TBL] [Abstract][Full Text] [Related]
20. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
Bates DW; Cullen DJ; Laird N; Petersen LA; Small SD; Servi D; Laffel G; Sweitzer BJ; Shea BF; Hallisey R
JAMA; 1995 Jul; 274(1):29-34. PubMed ID: 7791255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
